Thailand Breaks Merck's Patent For AIDS Drug
Going over the heads of big pharmaceutical companies, Thailand has issued the first compulsory license for a generic version of Merck & Co Inc.'s HIV-AIDS drug Efavirenz in an effort to...To view the full article, register now.
Already a subscriber? Click here to view full article